Interesting how the best cover-ups hide in plain sight....
... 1. The Present Situation
* The FBI has surely known for several months that the anthrax attack was an inside job. A government estimate for the number of scientists involved in the US anthrax program over the last five years is 200 people. According to a former defense scientist the number of defense scientists with hands-on anthrax experience and the necessary access is smaller, under 50. The FBI has received short lists of specific suspects with credible motives from a number of knowledgeable inside sources, and has found or been given clues (beyond those presented below) that could lead to incriminating evidence. By now the FBI must have a good idea of who the perpetrator is. There may be two factors accounting for the lack of public acknowledgement and the paucity of information being released: a fear that embarrassing details might become public, and a need for secrecy in order to acquire sufficient hard evidence to convict the perpetrator.
# Possible Portrait of the Anthrax Perpetrator
* Insider in US biodefense, doctoral degree in a relevant branch of biology
* Middle-aged American
* Experienced and skilled in working with hazardous pathogens, including anthrax, and avoiding contamination
* Works for a CIA contractor in Washington, DC area
* Has up-to-date vaccination with anthrax vaccine
* Has clearance for access to classified information
* Worked in USAMRIID laboratory in the past, in some capacity, and has access now
* Knows Bill Patrick and has probably learned a thing or two about weaponization from him, informally
* Has had training or experience in covering evidence
* May have had an UNSCOM connection
* Has had a dispute with a government agency
* Has a private location where the materials for the attack were accumulated and prepared
* Worked on the letters alone or with peripheral encouragement and assistance
* Fits FBI profile
* Has the necessary expertise, access and a past history indicating appropriate capabilities and temperament
* Has been questioned by FBI
..."From the moment one saw that it was highly concentrated Ames strain anthrax, the first lead candidate should have been a U.S. laboratory with a military contract," says MIT's Jonathan King. "Instead, we heard no such public admission. Immediately they were talking about Iraq and al-Qaida, when the largest such facilities are in the U.S. That leads me to think two things: the U.S. government is covering up the fact that the most likely source of the anthrax was not al-Qaida, was not foreign terrorists, but was a home-grown individual. And secondly, it was turned into part of the anti-terrorist propaganda."
Indeed, while in the early days of the anthrax letter scare, U.S. political leaders said they were actively looking to see if there was a connection between the anthrax and Iraq and al-Qaida, those views are now in the minority. On Dec. 17, White House spokesman Ari Fleischer said that it is "increasingly looking like it was a domestic source." On Jan. 13, Homeland Defense Director Thomas Ridge told media, "the primary direction of the investigation is turned inward." Two weeks ago, at a New Jersey press conference, an FBI official said the investigation was focusing on a U.S. government scientist.
..."I think a number of us were surprised by some of the revelations" of secret bioweapons programs, says Elisa D. Harris, the former Clinton administration NSC official. Harris thinks it's possible the FBI itself is not aware of all of the biodefense work being contracted out by the U.S. government, because it is such a highly secretive and compartmentalized program.
Harris says she was shocked to read in the New York Times last September about biodefense research programs that she herself had not known about, although she had served for eight years in the White House as the point person for weapons of mass destruction nonproliferation issues.
On Sept. 4, 2001 -- just a week before the Sept. 11 attacks, the Times reported that from 1997-2000, the CIA conducted a program called Clear Vision, to build a model of a Soviet germ bomblet. The program was carried out at the West Jefferson, Ohio, labs of Battelle Memorial Institute, a defense and CIA contractor. In addition, the Times story reported, the Defense Intelligence Agency, the Pentagon's intelligence arm, hired Battelle last year to create a type of genetically enhanced version of anthrax, a "superbug," to see if the anthrax vaccine currently in use by the Pentagon was effective against it. A second Pentagon program, called Bacchus, involved building a germ factory in the Nevada desert from scratch, but reportedly did not use real germs, but simulants that mimic their dispersal.
"I was only aware of one of those three programs," Harris says. "I was never told by the Defense Department about the other two. I was also not aware that since the early 1990s, the U.S. Army has apparently been producing small quantities of dry, very potent Ames strain anthrax."
An FBI spokesman said he knew of no effort tohamper the bureau's investigation. But whatever is stalling the investigation -- the forensic complexity of the case, bureaucratic resistance to FBI scrutiny, or a darker scenario of the sort Rosenberg describes -- Harris and others say it's now clear the U.S. biodefense program lacks proper oversight. And some experts even think it could take a congressional investigation to get to the bottom of what has stalled the anthrax investigation -- especially to answer questions about why the FBI didn't beat a quicker path to U.S. bioweapons labs.
fas.org |
